Medici: On April 3, 500 shares were sold short through margin financing and securities lending, and the balance of margin trading and securities lending was 301 million yuan.

robot
Abstract generation in progress

News from Securities Star: On April 3, MediciBio (688202) bought 13.1789 million yuan worth of securities using financing, repaid financing of 27.3875 million yuan, resulting in net financing selling of 14.2086 million yuan, with a financing balance of 301 million yuan.

As for securities lending, on the day, 500.0 shares were sold via securities lending, 0.0 shares were repaid, resulting in net securities lending selling of 500.0 shares; the remaining securities lending volume was 8,125.0 shares. In the past 20 trading days, net securities lending selling occurred on 11 trading days.

The financing and securities lending balance was 301 million yuan, down 4.5% from yesterday.

Quick Knowledge

Financing and securities lending: An increase in the financing balance reflects that bullish sentiment in the market is strengthening; a decrease in the financing balance reflects that market caution is increasing or that bearish sentiment is strengthening. Correspondingly, an increase in the securities lending balance reflects that bearish sentiment in the market is intensifying; a decrease in the securities lending balance reflects that market caution is strengthening or that bullish sentiment is strengthening. It should be noted that, due to the financial leverage effect of financing and securities lending, financing and securities lending is also a double-edged sword for investors—like a magnifying glass. When trading is profitable, profits can grow multiple times; even in losses, losses can be magnified a lot.

The above content is compiled by Securities Star from publicly available information and generated by an AI algorithm (filing record No. 310104345710301240019). It does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin